Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BMS-986172
Cat. No.:
OB0425LY-173
Appearance:
Solid
Purity:
99.48%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
BMS-986172 is a selective GAT2 inhibitor mainly used to regulate the immune system.
Synonyms:
1808258-99-2; (2S)-4-[1-(Cyclopropylmethyl)pyrazol-3-yl]-2-[2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl]-5-(5-oxo-1H-tetrazol-4-yl)-2-(trifluoromethyl)-1,3-dihydropyridin-6-one; (6S)-4-[1-(Cyclopropylmethyl)-1H-pyrazol-3-yl]-3-(2,5-dihydro-5-oxo-1H-tetrazol-1-yl)-6-[2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl]-5,6-dihydro-6-(trifluoromethyl)-2(1H)-pyridinone; (S)-4-(1-(Cyclopropylmethyl)-1H-pyrazol-3-yl)-6-(2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl)-3-(5-oxo-4,5-dihydro-1H-tetrazol-1-yl)-6-(trifluoromethyl)-5,6-dihydropyridin-2(1H)-one
CAS No.:
1808258-99-2
Compound CID:
136970071
Formula:
C24H22F7N7O3
Formula Weight:
589.47
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
BMS-986172 can be used to study metabolic disorders such as obesity and NASH studies.
